pulmonary disorders
Mesothelioma
Prognosis for Mesothelioma
Prognosis remains poor despite novel therapeutic approaches such as immunotherapy. Median survival is approximately 6 to 18 months, depending on stage and histology ( Prognosis reference ). Epithelioid mesothelioma, which is the most common histological subtype, is associated with longer median survival than sarcomatoid mesothelioma. Aside from histologic subtype, prognostic indicators and biomarkers have limited prognostic value. 1.Alpert N, van Gerwen M, Taioli E. Epidemiology of mesothelioma in the 21(st) century in Europe and the United States, 40 years after restricted/banned asbestos use.Transl Lung Cancer Res2020; 9(Suppl 1), S28-S38. doi:10.21037/tlcr.2019.11.11 